# Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient

> **NCT03672994** · — · COMPLETED · sponsor: **University of Leicester** · enrollment: 650 (actual)

## Conditions studied

- Asthma
- COPD
- Heart Failure
- Community-acquired Pneumonia
- Healthy
- Breathlessness

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03672994
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-02
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03672994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03672994, "Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03672994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*